Epsilogen is a clinical-stage company pioneering radically new antibody therapeutics for oncology, focusing on the development of immunoglobulin IgE, IgA, and IgG-based therapeuti…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Epsilogen is a clinical-stage company pioneering radically new antibody therapeutics for oncology, focusing on the development of immunoglobulin IgE, IgA, and IgG-based therapeuti…
Vittoria Biotherapeutics is a clinical-stage company with a novel platform technology, Senza5, that powers a pipeline of highly differentiated immunotherapies designed to address…
Details are not available yet. The company remains listed.
Acesion Pharma ApS is a Danish biotech company pioneering the development of safe and efficacious antiarrhythmic drugs for the treatment of atrial fibrillation, the most common ty…
ShiraTronics is a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic migraine, aiming to improve the quality of life for those…
Ensho Therapeutics is a clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory bowel disease, particularly throu…
Odyssey Therapeutics is focused on transforming the standard of care for patients with autoimmune and inflammatory diseases by targeting upstream signaling nodes and mechanisms in…
Nuvig Therapeutics is pioneering novel therapies for chronic autoimmune diseases, focusing on next-generation immune modulators that treat underlying inflammatory conditions witho…
Alveus Therapeutics is focused on developing next-generation metabolic therapies aimed at sustainable weight loss and improved patient outcomes in the obesity treatment landscape.
Altay Therapeutics is focused on developing small molecules that target transcription factors to address serious diseases, including facioscapulohumeral muscular dystrophy (FSHD)…